JNJ BUE Week ended 24 Jul 2026

Weekly Investor Report

Johnson & Johnson · Healthcare · Drug Manufacturers - General

Open interactive chart View report data Download investor PDF
Latest close 28,060 ARS
5.5% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 18.3% above the Trend Line and sits at 95.4% of its 52-week range. The latest completed week returned 5.5%, after a 7.2% four-week move. The latest news-sentiment score is 52/100. Near-term considerations: price is close to its 52-week high.

Setup score 76 out of 100
Latest Close 28,060 ARS 24 Jul 2026
1W Return 5.5% latest completed week
4W Return 7.2% short-term follow-through
12W Return 22.0% quarterly tape
Trend Breadth 100.0% 52 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • The trend backdrop is active with a 55-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 3 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 5.5% Latest completed week; four-week move 7.2%. Indicator stack 100/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 59.05% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 52/100 30 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 18.3% above the Trend Line and sits at 95.4% of its 52-week range. The latest completed week returned 5.5%, after a 7.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8012-week average 0.70

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership8/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.80Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 7.2% over four weeks, 22.0% over 12 weeks, and 94.2% over one year. The current trend has remained active for 55 consecutive weeks.

Performance by holding period

1W5.5%
4W7.2%
12W22.0%
26W26.6%
52W94.2%
Active trend streak55 weeks
Active weeks in one year52
Trend breadth100.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.00Latest activity-pressure read.
Pressure change460.9%Four-week change in activity pressure.
Leadership6.91Latest relative-leadership reading.
RS change1.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 30 relevant articles.

6 positive · 21 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-2.3%Distance below the 52-week high.
13-week volatility4.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+9.9%Week of 26 Jun.
Worst week-4.5%Week of 8 May.
Latest week+5.5%Week of 24 Jul.

Shape of recent returns

Strong gains5
Modest gains10
Flat weeks0
Modest losses9
Sharp losses2
Recent vol4.0%13-week weekly-return volatility.
Base vol3.6%52-week weekly-return volatility.
Up/down split33/19Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -2.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape77/100

Trend, activity pressure, participation, and risk combine to a 77/100 tape read.

 Indicator analysis62/100

Latest 12-week confirmation: trend 12/12, activity pressure 4/12, relative leadership 8/12.

Activity pressure 0.80; 3 reversal markers Next-Week ExpectancyPositive 59.05%

Next-week expectancy is positive with a 59.05% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment52/100

Weighted news tone is neutral across 30 relevant articles.

What Johnson & Johnson Stock Told You Before It Surged Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202628,060 ARS5.5%23,715 ARS15,003 ARS1.006.9146.3KOn
17 Jul 202626,600 ARS-0.7%23,483 ARS14,864 ARS1.024.5342.6KOn
10 Jul 202626,800 ARS-2.3%23,314 ARS14,732 ARS0.673.1120.8KOn
3 Jul 202627,420 ARS4.7%23,131 ARS14,597 ARS0.358.65109.4KOn
26 Jun 202626,180 ARS9.9%22,896 ARS14,457 ARS-0.286.7997.2KOn
19 Jun 202623,830 ARS-0.7%22,722 ARS14,325 ARS-0.88-7.215.5KOn
12 Jun 202624,000 ARS2.4%22,615 ARS14,209 ARS-0.90-7.939.1KOn
5 Jun 202623,430 ARS5.0%22,467 ARS14,091 ARS-0.94-1.9816.1KOn
29 May 202622,310 ARS-4.0%22,296 ARS13,975 ARS-0.95-8.6642.3KOn
22 May 202623,240 ARS3.3%22,184 ARS13,865 ARS-0.916.2762.6KOn
15 May 202622,500 ARS2.5%22,072 ARS13,749 ARS-0.958.9976.9KOn
8 May 202621,960 ARS-4.5%21,984 ARS13,638 ARS-0.904.8751.4KOn
1 May 202623,000 ARS1.1%21,873 ARS13,530 ARS-0.818.0046.2KOn
24 Apr 202622,750 ARS-0.4%21,747 ARS13,414 ARS-0.617.1368.6KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.